MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia

Myelin, myelin-related disorders, and psychosis

(2015) Michelle I. Mighdoll et al.   SCHIZOPHRENIA RESEARCH

Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy

(2015) Hans-Gert Bernstein et al.   SCHIZOPHRENIA RESEARCH

Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes

(2015) Johann Steiner et al.   Frontiers in Cellular Neuroscience

Myelination of the Nervous System: Mechanisms and Functions

(2014) Klaus-Armin Nave et al.   Annual Review of Cell and Developmental Biology

Antipsychotic treatment modulates glutamate transport and NMDA receptor expression

(2014) Mathias Zink et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive–compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders

(2014) Hans-Jürgen Möller et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Displacing hexokinase from mitochondrial voltage-dependent anion channel impairs GLT-1-mediated glutamate uptake but does not disrupt interactions between GLT-1 and mitochondrial proteins

(2014) Joshua G. Jackson et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: A light and electron microscopic study

(2014) R.C. Roberts et al.   NEUROSCIENCE

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay

(2014) Charlotte Welinder et al.   PLoS One

Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance

(2013) Chao Deng   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

(2013) Kenji Hashimoto et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

White matter deficits in first episode schizophrenia: An activation likelihood estimation meta-analysis

(2013) Li Yao et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Proteomic approaches to unravel the complexity of schizophrenia

(2012) Daniel Martins-de-Souza et al.   Expert Review of Proteomics

Oligodendroglia metabolically support axons and contribute to neurodegeneration

(2012) Youngjin Lee et al.   NATURE

Acute N-methyl-d-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats

(2012) I. Feinstein et al.   NEUROSCIENCE

Metabolic, hormonal and stress-related molecular changes inpost-mortempituitary glands from schizophrenia subjects

(2012) Divya Krishnamurthy et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3

(2011) Melanie Föcking et al.   ARCHIVES OF GENERAL PSYCHIATRY

A liquid–liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient samples

(2011) Lubbe Wiesner et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: Implications for brain energy metabolism and neurotrophic signaling

(2011) W.T. Regenold et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

(2011) Herbert Y. Meltzer et al.   PSYCHOPHARMACOLOGY

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

(2010) Daniel Martins-de-Souza et al.   ANTIOXIDANTS & REDOX SIGNALING

The Neuroproteomics of Schizophrenia

(2010) Jane A. English et al.   BIOLOGICAL PSYCHIATRY

Simultaneous Quantification of Apolipoprotein A-I and Apolipoprotein B by Liquid-Chromatography-Multiple- Reaction-Monitoring Mass Spectrometry

(2010) S. A. Agger et al.   CLINICAL CHEMISTRY

Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia

(2010) Daniel Martins-de-Souza et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Altered 13C Glucose Metabolism in the Cortico—Striato—Thalamo—Cortical Loop in the MK-801 Rat Model of Schizophrenia

(2010) Elvar M Eyjolfsson et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Targeted In-Gel MRM: A Hypothesis Driven Approach for Colorectal Cancer Biomarker Discovery in Human Feces

(2010) Ching-Seng Ang et al.   JOURNAL OF PROTEOME RESEARCH

Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia

(2010) Davide Carlino et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients

(2010) M K Chan et al.   MOLECULAR PSYCHIATRY

Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria

(2010) Leonardo M. Saraiva et al.   PLoS One

Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia

(2009) Daniel Martins-de-Souza   JOURNAL OF PSYCHIATRIC RESEARCH

Schizophrenia

(2009) Jim van Os et al.   LANCET

The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection

(2009) J. Haedicke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease

(2009) Jane A. English et al.   PROTEOMICS

Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring

(2009) K. E. Stephan et al.   SCHIZOPHRENIA BULLETIN

Stereologic investigation of the posterior part of the hippocampus in schizophrenia

(2008) Andrea Schmitt et al.   ACTA NEUROPATHOLOGICA